Skip to main content
Equibles
ADIL logo

ADIL · Adial Pharmaceuticals, Inc. · Investor Relations

Track ADIL — free

Use ADIL with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ADIL.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$4.86 -0.35 (-6.72%)
Rebalance outlook locked
Going-concern doubt — flagged Aug 14, 2026

Substantial doubt about the company's ability to continue as a going concern.

“the Company has concluded that there is substantial doubt about its ability to continue as a going concern.”
View the 10-Q filed Aug 14, 2026
Market Cap
$13.13M
Shares
2.63M

Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Key facts CIK 1513525 CUSIP 00688A304 13F (30d) 1 filings 1 filers Visit website Investor relations